Improving the identification of large vessel occlusion stroke during the emergency call: Protocol for the controlled LESTOR study with a stepped-wedge design
BackgroundLarge vessel occlusions (LVO) cause up to 30% of acute ischemic strokes. Mechanical thrombectomy is the first line treatment performed by neurointerventionalists. In Germany, neurointerventionalists are mostly situated in comprehensive stroke centres (CSC). Thus, long transport distances to CSCs may be necessary. The aim of this study is to implement and evaluate an intervention that involves lay first responders in the early identification of LVO, followed by a direct assignment to a CSC.Methods This controlled study with a stepped-wedge design and clustering of six emergency control centres in southwest Germany will stepwise implement LVO screening performed during the emergency call. Individuals with suspected LVO in both the control and intervention group (n=250) will undergo the usual treatment. In addition, emergency medical service dispatchers will screen patients in the intervention group for cortical stroke symptoms. For those with suspected LVO, air rescue is initiated immediately by the dispatchers. If the emergency medical service on scene confirms the suspected LVO, the patient benefits from accelerated transportation to the CSC. The primary endpoint is the clinical outcome measured by the modified Rankin Scale 90 days post-stroke. In addition, we will perform a qualitative process evaluation.Discussion We will assess the feasibility and cost-effectiveness of a systematic screening for symptoms of acute LVO implemented at the emergency control centre. The process evaluation will provide additional insight into how the participating emergency professionals perceive the intervention and the psychological impact on lay first responders. We hypothesize that early, pre-hospital identification of LVO patients and an optimized rescue chain will enable earlier treatment - especially in rural areas. We expect improved clinical outcomes of LVO patients and a better understanding for future studies with larger sample sizes.Trial registrationDRKS (German Clinical Trials Register), DRKS-ID: DRKS00022152. Registered 19th October 2020, https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00022152; WHO UTN: U1111-1253-5758.